Panuveitis
📧 Sign up to get email alerts when something new happens for Panuveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-12Clinical Trial Update: Ozurdex Monotherapy Trial [Phase 4]
The Phase 4 Ozurdex monotherapy trial for posterior uveitis, intermediate uveitis, and panuveitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU [Phase 2]
Phase 2 proof-of-concept study evaluating ESK-001 for active noninfectious uveitis (intermediate, posterior, or panuveitis) was terminated.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study [Phase 4]
A Phase 4 proof-of-concept trial evaluating ixekizumab for refractory non-infectious uveitis across posterior, anterior, intermediate, and p…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Ocular Sarcoidosis Open Label Trial of ACTHAR Gel [NA]
Completed open-label trial of ACTHAR Gel for ocular inflammatory conditions with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) [Phase 4]
Phase 4 trial update on Acthar Gel for inflammation of the eye's uvea, with terminated status and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis [Phase 3]
Phase 3 trial evaluating suprachoroidal CLS-TA injection for non-infectious uveitis has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Extension study update for patients with non-infectious uveitis who participated in CLS1001-301 (MAGNOLIA) has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis [Phase 3]
Phase 3 trial update for suprachoroidal CLS-TA injections in macular edema due to non-infectious uveitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis [Phase 1, Phase 2]
Clinical trial updates safety and efficacy of suprachoroidal triamcinolone acetonide delivered via microneedle for noninfectious uveitis, co…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis [Phase 2]
Phase 2 trial update on safety, tolerability, and efficacy of AEB071 for uveitis shows completed study; regulatory implications pending.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis [Phase 3]
Phase 3 trial assessing safety and efficacy of a FAI insert for chronic non-infectious posterior uveitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Sirolimus as Therapeutic Approach to Uveitis [Phase 1]
Phase 1 clinical trial evaluating sirolimus as a therapeutic approach for uveitis has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) [Phase 3]
Phase 3 trial comparing interferon alfa-2a versus cyclosporin A in severe ocular Behçet's disease (panuveitis) has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study [Phase 1, Phase 2]
An early-phase trial evaluating the safety, tolerability, and bioactivity of tocilizumab in adults with noninfectious uveitis (STOP-UVEITIS)…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis [Phase 3]
A Phase 3 trial of LX211 for posterior, intermediate, and pan-uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis [Phase 3]
A Phase 3 study evaluating the efficacy and safety of LX211 in active non-infectious anterior uveitis (including panuveitis) has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis [Phase 3]
Phase 3 trial evaluating LX211 for non-infectious uveitis has completed. The study examined posterior, intermediate, and pan-uveitis.
-
CLINICAL_TRIALS research · 2006-12-05Clinical Trial Update: Quality of Life and Visual Function in Uveitis Patients
An update on a clinical trial evaluating quality of life and visual function in uveitis patients (anterior or posterior). The brief notes th…
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis [Phase 3]
Phase 3 trial evaluating difluprednate ophthalmic emulsion for severe uveitis and panuveitis has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis [Phase 3]
Phase 3 study of difluprednate ophthalmic emulsion for anterior uveitis and panuveitis has completed.